Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06310668
Other study ID # CBT IN substance use disorder
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date October 2024

Study information

Verified date March 2024
Source Egyptian Medical Syndicate
Contact hassan M sonbol
Phone +201003903567
Email hassansonbol@mans.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim of the study: In this study, the change in emotional intelligence will be assessed before and after group CBT sessions in male patients with substance use disorder in the inpatient department of the addiction unit at Mansoura University Hospital.


Description:

Between the ages of fifteen and sixty-four, 5% of the global population, or nearly 200 million people, reported consuming at least one illegal substance per year. According to the 2008 World Drug Report, cannabis has a prevalence of 3.8%, compared to 0.6% for amphetamines and opiates, 0.3% for cocaine and heroin, and 0.2% for ecstasy. A cross-sectional study by [1] in Egypt with 2552 participants found that sedatives (8.7%) were the most commonly abused drugs, followed by alcohol (6.7%), cannabinoids (6.6%), and tramadol (2.4%). The prevalence of drug use was 8.9% for cigarette smoking followed by sedatives (4.3%), hashish (3.6%), alcohol (2.7%), cannabinoids (1.4%,) and tramadol (1.0%). Lander et al. [2] believed that substance use disorder (SUD) is one of the most severe psychosocial traumas posing environmental, psychological, behavioral, and emotional challenges to individuals. It can cause obstacles for persons, families, and cultural foundations, endangering countries' dynamics. SUD is a brain disorder that impacts the person's behavior, manifests as psychological and physiological symptoms; and persists for a long duration despite its harmful and detrimental consequences. Previous research has shown that different factors impact starting and following addiction. These factors are; 1) Individuals, such as the presence or lack of personality traits that make an individual vulnerable to addiction, for example, non-assertiveness as an individual factor. 2) Social factors, such as parental addiction, lack of parental control, availability of substances, presence of addicted peers, and so on [3]. Emotional intelligence (EQ) is a relatively recent behavioral model rising to prominence with Daniel Goleman's 1995 Book called 'Emotional Intelligence'. The early emotional intelligence theory was originally developed during the 1970s and 80s by the work and writings of psychologists Howard Gardner (Harvard), Peter Salovey (Yale), and John 'Jack' Mayer (New Hampshire) [4]. Emotional intelligence consists of the ability to motivate individuals such as endurance against frustration, impulse control, mood modification, and avoiding destructive stress to prevent mental disorders [5]. Emotional intelligence is a set of non-cognitive skills and abilities that can help a person deal with environmental stressors, according to [6]. Azzam and Elghonemy's [7] research demonstrated that emotional regulation was associated with mood improvement and a higher likelihood of SUD recovery. They found emotional intelligence to be an important factor in the treatment of substance use. [8] suggested that improvements in EI through treatment interventions can be an effective way to improve not only EI but also psychiatric symptoms both for the short term and the long term after rehabilitation.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 84
Est. completion date October 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: 1. Male patients with DSM5 diagnosis of substance use disorder 2. Age range 18 to 55 years 3. Agreeing to participate in the research and giving written informed consent 4. Average IQ as evidenced by the Wechsler Adult Intelligence scale Exclusion Criteria: 1. Psychiatric comorbidities 2. Any neurological or medical conditions interfering with the cognitive abilities 4-Illiterate patients

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
group cognitive behavioral therapy sessions
12 group CBT sessions based on catching and challenging cognitive errors and behavioral techniques to deal with substance use problems

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Egyptian Medical Syndicate

References & Publications (8)

3-Sho'aKazemi M. The comparative analysis of the relationship between coping strategies and attitude toward drug addicts (Persian). Addiction Studies; 2008.

4-Nazari K, Emami M. Emotional Intelligence: Understanding, applying, and measuring. Journal of Applied Sciences Research. 2012;8(3):1594-1607.

5-Bar-on R. The Emotional Quotient Inventory (EQ-i). A Test of Emotional Intelligence. Jossey. Bass; 2006.

6-Shareh, H., & Foshtanqi, K. (2019). The role of emotional intelligence and marital satisfaction in women's quality of life: Structural equation modeling. Journal of Fundamentals of Mental Health, 21(2), 109-120.

7-Azzam H, Elghonemy S. Emotional intelligence and substance abuse: A possible relation. Current Psychiatry. 2008; 15:113.25.

8-Henning, C., Crane, A. G., Taylor, R. N., & Parker, J. D. (2021). Emotional intelligence: relevance and implications for addiction. Current Addiction Reports, 8, 28-34.

Kabbash I, Zidan O, Saied S. Substance abuse among university students in Egypt: prevalence and correlates. East Mediterr Health J. 2022 Jan 31;28(1):31-40. doi: 10.26719/emhj.22.001. — View Citation

Lander L, Howsare J, Byrne M. The impact of substance use disorders on families and children: from theory to practice. Soc Work Public Health. 2013;28(3-4):194-205. doi: 10.1080/19371918.2013.759005. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary emotional intelligence Trait Emotional Intelligence Questionnaire (TEIQue-SF):
The Trait Emotional Intelligence Scale (Petrides, 2009b) includes 30 items that assess the following four factors: well-being, self-control, sociability (each with six items), and emotionality (eight items), as well as four additional items 3, 14, 18, and 29, which do not belong to any factor and directly contribute to the evaluation of the overall degree of the trait emotional intelligence, as indicated by the scoring key. The questionnaire is graded on a seven-point Likert scale, with responses ranging from 1 (strongly disagree) to 7 (strongly agree), with higher scores indicating higher emotional intelligence. This TEIQue-SF scale has been used in numerous studies (Cooper & Petrides, 2010; Perera, 2015) owing to its good psychometric properties. The Arabic version was validated by Al-Dassean, (2023).
6 months
See also
  Status Clinical Trial Phase
Completed NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Active, not recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2